跳至主要内容
临床试验/NCT06210035
NCT06210035已完成不适用

Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease

University of Southern California1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2024年1月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
94
试验地点
1
主要终点
Change in Plasma Amyloid Beta (Aβ) Levels

研究概览

简要总结

In the current study, we will examine how two types of concentration meditation practices affect plasma biomarkers of Alzheimer's Disease (AD). We will also examine the effects of the two types of meditation practices on emotional well-being and episodic memory. Healthy adults aged 18-35 who meet all eligibility criteria will be invited to this study. Participants will be asked to engage in one week of daily meditation practice or no-intervention control task at home. They will also be asked to visit the lab twice, once before and once after the intervention, to provide blood samples to assess plasma biomarkers of AD and to complete emotion questionnaires and a memory test.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Fluent in English
  • Aged between 18-35 years old
  • Agree to provide blood samples
  • Healthy adults who weigh at least 110 pounds
  • Agree to devote 40 minutes daily to this study for a week

排除标准

  • Have a disorder that would affect heart rhythm or function (e.g., abnormal cardiac rhythm, dyspnea, heart disease including coronary artery disease, angina and arrhythmia)
  • Regularly practicing any relaxation, meditation or yoga that involve breathing focused practices lasting for more than an hour each week

结局指标

主要结局

Change in Plasma Amyloid Beta (Aβ) Levels

时间窗: Measured from blood draws before and after a one-week intervention

The investigators computed an aggregate Z-score based on plasma Aβ40 and Aβ42 levels (pg/mL). A Z-score of 0 represents the sample mean. Higher values indicate a greater level of plasma Aβ, which in cognitively normal individuals has been found to be associated with a higher risk of converting to Alzheimer's disease (Song et al., 2011). They conducted a 2 (time: pre, post) × 3 (condition) ANOVA to test for a time × condition interaction in plasma Aβ levels, assessing group differences in change over time.

Change in Plasma Ab42/40 Ratio

时间窗: Measured from blood draws before and after a one-week intervention

The investigators conducted a 2 (time: pre, post) × 3 (condition) ANOVA to test for an interaction effect on plasma Ab42/40 ratios. The plasma Ab42/40 ratio was calculated by dividing the plasma Ab42 concentration (pg/ml) by the plasma Ab40 concentration (pg/ml). A higher plasma Ab42/40 ratio indicates better outcome (i.e., greater brain clearance).

次要结局

  • Change in Plasma pTau-181/Tau Ratio(Measured from blood draws before and after a one-week intervention)
  • Change in Emotional Well-being(Measured before and after a one-week intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mara Mather

Professor

University of Southern California

研究点 (1)

Loading locations...

相似试验